Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...

Cognito Therapeutics has reached its enrolment goal for the randomised, sham-controlled HOPE Study investigating the Spectris ...

A surprising discovery about how brain cells handle sugar could shift how scientists approach dementia and Alzheimer’s ...

Cognition Therapeutics Inc (NASDAQ: CGTX) continued to gain 12.10% in after-hours trading on Thursday, after a 20.82% surge ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

Alzheimer's disease (AD) is a common, debilitating neurodegenerative disease affecting about 10% of people over the age of 65 ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

Pinpointing who will and won’t get Alzheimer’s disease is tricky for doctors, but new research suggests it may soon get ...

Deep sleep could forestall the declines in brain health that can eventually lead to Alzheimer's disease, the most common form ...

GREEN BAY, Wis. (WBAY) - Brad Spakowitz heads into the holiday weekend with a burst of ideas and explosion of excitement.